Andrade, M. de O. (2026) “Immune-related adverse events among patients with early-stage triple-negative breast cancer treated with pembrolizumab plus chemotherapy: real-world data from the Neo-Real/ GBECAM-0123 study”, Mastology. Rio de Janeiro, 35(suppl.1). doi: 10.29289/259453942025V35S1030.